Leading biopharmaceutical company Pfizer has unveiled Cibinqo and Staquis, two innovative therapies designed to address eczema across its varying stages, now available in Malaysia. The announcement, ...

The JP Morgan Healthcare Conference, which is being held in San Francisco this year, has been much more active than last year. Among some of the top news at the conference were M&A deal announcements ...

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...

R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 ...

Technoderma Medicines has completed its phase 2a trial of TDM-180935 for the treatment of atopic dermatitis, demonstrating ...

LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 /General Enterprise Ventures, Inc. (OTC PINK:GEVI), a pioneer in the future of sustainable fire protection solutions, and its subsidiary, Mighty Fire ...

Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a ...

Verastem (VSTM) announced it has exercised early the option to license from GenFleet Therapeutics VS-7375, an oral and selective KRAS G12D ...

H.C. Wainwright analyst Joseph Pantginis has maintained their bullish stance on BMEA stock, giving a Buy rating yesterday.Stay Ahead of the ...

(HealthDay News) — The machine learning system SCORPIO can predict patient outcomes with immune checkpoint inhibitor (ICI) therapy across diverse cancer types and health care settings, according to a ...

A prediction for 2025 by Marci Chodroff, M.D., vice president of Medical Affairs at Prime Therapeutics and Managed Healthcare ...

UNC Lineberger Comprehensive Cancer Center researchers have discovered a three-drug combination that enhances the generation ...